39 results on '"Newman, Frances K."'
Search Results
2. Prevaccine Determination of the Expression of Costimulatory B7 Molecules in Activated Monocytes Predicts Influenza Vaccine Responses in Young and Older Adults
3. Reducing the Dose of Smallpox Vaccine Reduces Vaccine-Associated Morbidity without Reducing Vaccination Success Rates or Immune Responses
4. Interferon-γ-Mediated Antiviral Immunity against Orthopoxvirus Infection Is Provided by γδ T Cells [with Reply to Agrati et al]
5. Flow-Cytometric Detection of Vaccinia-Induced Memory Effector CD4⁺, CD8⁺, and γδTCR⁺ T Cells Capable of Antigen-Specific Expansion and Effector Functions
6. Evaluation of Combined Live, Attenuated Respiratory Syncytial Virus and Parainfluenza 3 Virus Vaccines in Infants and Young Children
7. Induction of Human T Cell-Mediated Immune Responses after Primary and Secondary Smallpox Vaccination
8. Immunity to Influenza in Older Adults with Chronic Obstructive Pulmonary Disease
9. Dose-Dependent Neutralizmg-Antibody Responses to Vaccinia
10. Phase 2 Evaluation of Parainfluenza Type 3 Cold Passage Mutant 45 Live Attenuated Vaccine in Healthy Children 6-18 Months Old
11. Stability of Undiluted and Diluted Vaccinia-Virus Vaccine, Dryvax
12. Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax ® in healthy vaccinia-naive adults
13. Clinical and immunologic responses to multiple doses of IMVAMUNE ® (Modified Vaccinia Ankara) followed by Dryvax ® challenge
14. Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults
15. Serum antibody responses after intradermal vaccination against influenza
16. Response to smallpox vaccine in persons immunized in the distant past
17. Dose-related effects of smallpox vaccine
18. Clinical responses to undiluted and diluted smallpox vaccine
19. Immune Status in a Primary Smallpox Vaccinee Who Failed to Develop an Immunization Site Reaction
20. Influenza Virus Vaccination of Patients With Chronic Lung Disease*
21. Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors
22. Increased Anti-Influenza a Virus Cytotoxic T Cell Activity following Vaccination of the Chronically Ill Elderly with Live Attenuated or Inactivated Influenza Virus Vaccine
23. A Live Human Parainfluenza Type 3 Virus Vaccine Is Attenuated and Immunogenic in Healthy Infants and Children
24. Immunization of Infants and Young Children with Live Attenuated Trivalent Cold-Recombinant Influenza a H1N1, H3N2, and B Vaccine
25. Multidose, Live Attenuated, Cold-Recombinant, Trivalent Influenza Vaccine in Infants and Young Children
26. Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax® in healthy vaccinia-naive adults
27. Flow-Cytometric Detection of Vaccinia-Induced Memory Effector CD4+, CD8+, and γδTCR+ T Cells Capable of Antigen-Specific Expansion and Effector Functions.
28. Protection of weanling hamsters from experimental infection with wild-type parainfluenza virus type 3 (para 3) by cold-adapted mutants of para 3.
29. Induction of Mucosal Antibodies by Live Attenuated and Inactivated Influenza Virus Vaccines in the Chronically III Elderly.
30. Reply to Agrati et al.
31. Recombinant gp160 vaccination schedule and MHC HLA type as factors influencing cellular responses to HIV-1 envelope glycoprotein
32. Safety and immunogenicity of IMVAMUNE smallpox vaccine using different strategies for a post event scenario.
33. CD4+ T Cells Provide Intermolecular Help To Generate Robust Antibody Responses in Vaccinia Virus-Vaccinated Humans.
34. Antibody Profiling by Proteome Microarray Reveals the Immunogenicity of the Attenuated Smallpox Vaccine Modified Vaccinia Virus Ankara Is Comparable to That of Dryvax.
35. CD4+ T cells provide intermolecular help to generate robust antibody responses in vaccinia virus-vaccinated humans.
36. Analysis of variola and vaccinia virus neutralization assays for smallpox vaccines.
37. Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response.
38. Flow-cytometric detection of vaccinia-induced memory effector CD4(+), CD8(+), and gamma delta TCR(+) T cells capable of antigen-specific expansion and effector functions.
39. Improved assay to detect neutralizing antibody following vaccination with diluted or undiluted vaccinia (Dryvax) vaccine.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.